PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Am J Obstet Gynecol. Author manuscript; available in PMC 2013 October 1.
Published in final edited form as:
PMCID: PMC3398205
NIHMSID: NIHMS360271

Factors influencing urinary fistula repair outcomes in developing countries: a systematic review

Vera FRAJZYNGIER, PhD, MPH, Joseph RUMINJO, MD, and Mark A. BARONE, DVM, MS

Abstract

We reviewed literature examining predictors of urinary fistula repair outcomes in developing country settings, including fistula and patient characteristics, and peri-operative factors. We searched Medline for articles published between January 1970 and December 2010, excluding articles that were 1) case reports, cases series or contained 20 or fewer subjects; 2) focused on fistula in developed countries; and 3) did not include a statistical analysis of the association between facility or individual-level factors and surgical outcomes. Twenty articles were included; 17 were observational studies. Surgical outcomes included fistula closure, residual incontinence following closure, and any incontinence (dry vs. wet). Scarring and urethral involvement were associated with poor prognosis across all outcomes. Results from randomized controlled trials examining prophylactic antibiotic use and repair outcomes were inconclusive. Few observational studies examining peri-operative interventions accounted for confounding by fistula severity. We conclude that a unified, standardized evidence-base for informing clinical practice is lacking.

Keywords: Developing countries, obstetric fistula, surgical outcomes, systematic review

Introduction

An obstetric fistula, or abnormal opening between the vagina and the bladder or rectum, is a devastating condition. It is caused by prolonged obstructed labor: the fetus’s head compresses soft tissues of the bladder, vagina and rectum against the woman’s pelvis, cutting off blood supply, causing these tissues to die and slough away. It can result in urinary or fecal incontinence, or both; concomitant conditions may include painful rashes resulting from constant urine leakage, amenorrhea, vaginal stenosis, infertility, bladder stones, and infection.1 Women suffering from obstetric fistula may be abandoned by their husbands and ostracized by their communities. While global prevalence is unknown, the self-reported lifetime prevalence of fistula symptoms reported in Demographic and Health Surveys has ranged from .4% in Nigeria2 to 4.7% in Malawi.3

Less frequently, genito-urinary and rectovaginal fistulas may result from sexual violence, malignant disease, radiation therapy, or surgical injury (most often to the bladder during hysterectomy or Caesarean section (C-section)). Surgical injury, malignant disease and radiation therapy, are the predominant cause of the condition in industrialized countries; indeed, obstetric fistula rarely occurs in settings where competent emergency obstetric care is readily accessible. Fistulas resulting from surgical injury are characterized by discrete wounding of otherwise normal tissue1 while both obstructed labor and radiation may lead to extensive ischemia and scarring.

There are two broad research priorities in the vaginal fistula (hereafter referred to as “fistula”) repair field. One is to evaluate which operative techniques and methods of perioperative patient management are most effective and efficient for fistula closure and prevention of residual incontinence following successful closure. Many fistula surgeons have developed their own methods through experience4 and thus a wide variety of procedures and methods are commonly used. The other need is for evidence to support the development of a standardized evidence-based system for classifying fistula prognosis, and at a minimum, a system prognostic for fistula closure. Currently at least 25 systems are used5 and parameters measured by these classification systems vary greatly. To-date, the prognostic value of only two systems6-7 has been tested; these analyses were conducted following the adoption of these systems, rather than to create them. In order to develop a prognostic system, it is necessary to determine which patient and fistula characteristics independently predict outcomes, and to identify the minimal parameters required for accurate prognosis, since the simpler a classification system, the more likely it is to be used. A prognostic classification system would not only facilitate the evaluation of surgical success rates across facilities, but also the effectiveness of interventions independent of confounding by patient or fistula characteristics; it would also facilitate the comparative analysis of studies that examine treatment outcomes.

In light of the above priorities, and increased research on obstetric fistula in recent years, we aimed to systematically review and synthesize the evidence regarding factors that may influence fistula repair outcomes in developing countries, including fistula and patient characteristics, as well as peri-operative factors (e.g. peri-operative procedures and other aspects of service delivery). Based on these findings, our goal was to identify future research priorities in order to fill existing knowledge gaps.

Methods

We conducted a systematic review of the Medline database to identify relevant publications by searching for articles published from 1970-2010, using the following topic headings: “obstetric fistula,” “vaginal fistula,” “urinary bladder fistula,” “vesicovaginal fistula” and “fistula”; this yielded 6,589 articles. The search was refined by excluding the MeSH headings clearly unrelated to the female genital fistula of interest, namely “infant,newborn,” “male,” “kidney transplantation,” “adenocarcinoma,” “radiotherapy,” “penis,” “animals,” “prostatectomy,” “Crohn’s Disease” “child, preschool” “radiation injuries,” and “kidney diseases.” This yielded 2,437 articles. We reviewed titles of these articles excluding those clearly not meeting our eligibility criteria. This resulted in 526 articles whose abstracts were reviewed to determine eligibility.

Articles included in the final analysis met the following criteria: peer reviewed; original research; focused on predictors of fistula repair outcomes; published after 1970; and written in French or English. Articles were excluded if they were case reports, cases series or contained 20 or fewer subjects; focused on fistula in developed countries (since most of these are secondary to surgery or malignancy, and results from such studies may not be generalizable to developing countries where obstetric fistula predominates); and did not statistically analyze associations between predictors and surgical outcomes. Review of references of published papers yielded one additional article that met the inclusion criteria. One additional article was identified via an internet search engine (Google).(Figure 1)

Figure 1
Flow diagram of study eligibility

Twenty articles examining predictors of fistula surgery outcomes were identified (Table 1), and data on sample characteristics, study design, exposures, outcomes, and effect estimates were abstracted by one author. Fourteen studies reported results of retrospective record reviews,8-21 three were prospective studies,6-7, 22 and three were randomized controlled trials (RCTs).23-25 A minority of the observational studies6-7, 9, 17-19 accounted for potential confounding with multivariate analysis. Sample sizes ranged from 34-1045; half had samples over 1006-9, 11, 13, 17-19, 24 and one-quarter had samples under 50.14-16, 25 Studies examined a variety of predictors (Table 2): eight examined patient or fistula characteristics,6-10, 15, 21-22 six examined peri-operative factors,11-15, 20, 24 and five examined both.16-19, 25 Three studies were restricted to women undergoing primary repairs.7, 17, 24

Table 1
Publications examining predictors of fistula repair outcomesin developing country settings
Table 2
Predictors studied across the articles reviewed,a by study outcome and results

Definitions of “successful repair” varied, including fistula closure, no residual incontinence among those with closed fistula, or no incontinence (i.e. fistula closure and no residual incontinence) (Table 2). Most studies assessed associations between predictors and repair outcomes at discharge (typically 2-3 weeks after repair). There were several exceptions. Bland and Gelfand assessed outcome at six weeks following repair.22 Safan and colleagues25 and Morhason-Bello and colleagues20 examined outcome three months following repair, and Chigbu et al. assessed outcome at 6 weeks or 3 months after repair, depending on data availability (personal communication H. Onah, July 2011).12 For those studies for which we were unable to determine timing of outcome assessment8, 10, 12, 15-16 we assume that outcome was assessed at discharge.

Results

The relationship between patient characteristics and surgical outcomes

Age at repair was the most common characteristic studied; however, neither age at repair nor age at fistula occurrence predicted repair prognosis independent of other fistula or patient characteristics. Evidence to support the role of parity, duration of leakage, and mode of delivery on repair outcomes was similarly weak, and in the case of parity, contradictory. In bivariate analysis, Lewis et al.9 found that higher parity predicted any incontinence, while Browning18 and Kirschner19 found that lower parity reduced the risk of negative outcomes. These associations were not significant in multivariate analysis, however. Other factors related to the causative delivery or obstetric history were evaluated by only one study, in unadjusted analyses.19 Finally, the only patient comorbidity evaluated was urinary bilharziasis. Bland and Gelfand (1970) examined the association between Schistosoma haematobium and fistula closure, hypothesizing that bladder wall fibrosis caused by urinary bilharziasis complicates closure and healing. Indeed, 70% of S. haematobium negative patients healed successfully, compared to 37.5% of those positive.22 The study was small, and only unadjusted associations were tested.

The relationship between fistula characteristics and surgical outcomes

In contrast to patient characteristics, stronger evidence supports the negative influence of fistula characteristics, particularly vaginal scarring and urethral involvement (including circumferential damage, i.e. complete separation of the urethra from the bladder), on repair outcomes. Each of the studies examining vaginal scarring found an association with repair outcome, including multivariate analyses demonstrating an independent effect of vaginal scarring on closure (OR=2.67, 95%CI: 1.36-3.75),17 residual stress incontinence following closure (OR=2.4, 95%CI: 1.5-4.0)18 and any incontinence (OR=3.21, 95%CI: 2.10-4.89).19 One study found a dose-response, with higher degree of scarring resulting in greater likelihood of any incontinence.9 Similarly, three large studies found an independent association between increased degrees of urethral involvement and failure to close the fistula (OR=1.56, 95%CI: 0.94-2.59),17 residual incontinence(OR=8.4, 95%CI: 3.9-17.9)26 and any incontinence (OR=3.58, 95%CI: 2.42-5.31 and OR=8.04, 95%CI: 3.18-20.31 for partial and complete loss of the urethra, respectively).19 The latter study also found that “lower” fistulas (urethra-vaginal, circumferential, juxta-urethral, fistula behind the symphisis pubis) and “large” fistulas (entire anterior vagina destroyed) were significantly associated with incontinence.19 Finally, a smaller study found a marginal association (OR=2.41; p=.08) between partial urethral damage, and no association between complete urethral destruction, and any incontinence.9

One large study found that as fistula size increased, the likelihood of residual incontinence decreased, after adjusting for other fistula and patient characteristics (OR=1.34, 95%CI: 1.16-1.56),26. The only study7 examining fistula diameter, however, found no association with fistula closure. Both studies examining the association between bladder size and repair outcomes found that smaller size independently predicted failure to close the fistula (OR=2.27, 95%CI: 1.36-3.75)17 and incontinence following closure (OR=4.1, 95%CI: 1.2-13.8).18 Finally, evidence was insufficient regarding the role of prior repair, ureteric involvement, combined VVF/RVF or multiple fistulas on repair outcomes.

Components of two existing classification systems have been correlated (post-development) with patient outcomes. One study examined the influence of Goh’s classification system components (Table 3) on incontinence following successful closure, independent of other components of the classification system (no multivariate analyses were conducted to assess independent predictors of closure). Women with Type 1 fistulas (fistulas furthest from the urethral opening) were more likely to be continent than women with Type 4, with a trend towards decreasing continence from Type 2 to 4. Women with larger fistulas, and those with special considerations (including scarring), were less likely to be continent.6 These findings corroborate those on urethral involvement and scarring discussed above, and contribute evidence regarding the role of fistula size on residual incontinence. Raassen and colleagues tested the ability of components of Waaldijk’s classification system (Table 3) to predict fistula closure and residual incontinence among 581 fistula patients. Multivariate analyses assessed predictors of closure only, and revealed no independently predictive components.7

Table 3
Waaldijk and Goh fistula classification systems

The relationship between peri-operative factors and surgical outcomes

Evidence is sparse regarding the effectiveness of peri-operative factors on repair outcomes. Two RCTs examining antibiotic use23-24 had indeterminate findings. Tomlinson and Thornton examined whether intra-operative intravenous ampicillin reduced the failure rate of VVF repair. The authors hypothesized that reducing surgical wound infections improves fistula healing; however, they actually found a trend towards higher failure to heal1 and more incontinence in the intervention group (OR=2.1, 95%CI: 0.75-6.1).23 More recently, Muleta and colleagues examined the effects of either 80 mg Gentamycin IV or extended use of Amoxicillin, chloramphenicol or cortimexazole on fistula closure, finding that the Gentamycin arm trended toward higher closure rates (94% vs. 89.4%, p=.04; risk difference (RD)=5.1%, 95%CI: −0.4-10.6).24

Four studies examined the effect of Martius flap interpositioning, with conflicting results. Only one 14 found a positive effect on fistula closure; it was small and reported only unadjusted associations. While another found the Martius Flap to be associated with significantly higher risk of residual incontinence after repair among all fistulas, urethral fistulas only and Goh Type 2 fistulas,11 analyses did not adjust for multiple confounding factors simultaneously. Three retrospective studies examined route of repair12, 16, 20; they were small, detected varying directions of effect, and reported only unadjusted associations (though two12, 20 restricted the sample by type of fistula). The only study examining double-versus single-layer closure found no association after adjusting for bladder size (OR=1.17, 95%CI: 0.73-1.87), and relaxing incision was associated with incontinence (OR=1.91, 95%CI: 1.25-3.11), controlling for a limited set of fistula characteristics.19 Finally, one study examined the unadjusted influence of duration of bladder catheterization on repair outcomes: patients catheterized for 12 and 14 days had significantly greater likelihood of residual incontinence than those catheterized for 10 days; no difference in closure was detected.13 No other studies of peri-operative procedures, nor any studies examining the influence of repair context or provider experience on repair outcomes, have been published.

Conclusion

We systematically reviewed literature examining predictors of fistula repair outcomes. Most studies were observational, and few conducted analyses that would permit assessment of independent effects of individual predictors. Patient and fistula characteristics were most frequently studied, with multiple studies of some predictors. Studies of peri-operative factors have been less frequently replicated.

Evidence in the published literature failed to demonstrate an independent role of patient characteristics in predicting repair outcome. The relationship between some patient characteristics and repair outcomes may be mediated by fistula characteristics. For instance age is related to pelvic size, and may thereby influence the degree of damage caused by the obstructed labor, in turn influencing the prognosis of the repair. The influence of patient comorbidities on repair outcomes has rarely been studied; further evaluation is warranted, as comorbidities may be addressed pre-operatively.

Unlike patient characteristics, the weight of evidence indicates that certain fistula characteristics, particularly scarring and urethral involvement, predict poor repair prognosis. These findings are biologically plausible. Urethral fistula repair is a complex procedure. It necessitates reconstruction of surviving tissues into a supple functional organ, which acts both as a passageway for urine, and as a “gatekeeper,” ensuring that passage of urine occurs at appropriate times.27 Reconstruction of the urethra may not necessarily re-establish normal physiology of urethral function and the urethral/bladder voiding reflex. Extensive scarring not only inhibits access to the fistula, but requires use of unhealthy tissue to close the defect.27 Vaginal scarring can also lead to incontinence, if it prevents normal urethral functioning.18

The relationship between other fistula characteristics and repair outcomes is less clear. While two large studies found that as fistula size increases, likelihood of continence following fistula closure decreases,6, 18 the samples of the two studies overlapped somewhat (personal communication A. Browning, July 2011). Nonetheless, these findings are not surprising. It has been suggested that more extensive dissection which may be required for larger fistulas can cause post-operative scarring around the urethra, holding the urethra open.18 The results of two studies showing an association between smaller bladder size and failure of fistula closure24 and incontinence following closure,18 are also biologically plausible. Loss of bladder tissue means the surgeon must close defects with limited remnants of (frequently damaged) bladder tissue; the small resulting bladder size may affect its capacity to retain urine. In addition, while no studies detected an independent association of prior repair and repair outcomes, prior repair has been correlated with degree of vaginal scarring.8 Thus, prior repair may be an indirect cause of negative repair outcomes, via vaginal scarring, which could explain the lack of an independent role of prior repair after adjusting for vaginal scarring seen in two studies.9, 18 Additional studies with large sample sizes are needed to study relatively rare exposures such as ureteric involvement.

Few studies have examined the role of peri-operative factors and all but three were observational designs. Results of the three RCTs 23-25 are difficult to interpret. The findings that prophylactic antibiotic use trended towards higher operative failure and more incontinence compared to no antibiotic use are surprising and counter-intuitive, given the expectation that reducing wound infections would promote fistula closure.23 A recent trial comparing single-dose versus extended antibiotic use demonstrate a marginally significant benefit in favor of single-dose antibiotics, though reasons for such a trend are unclear.24 However, the confidence intervals for both results were compatible with a chance result. The RCT comparing fibrin glue to Martius flap interpositioning was inconclusive, due to its small sample size.25

Observational studies examining medical interventions are subject to confounding by indication, or prognosis, whereby providers prescribe vigorous therapy when the outlook is poor.28 This applies to the observational studies examining peri-operative factors related to fistula surgery, reviewed here. For instance, Nardos et al.13 demonstrated that women catheterized for fewer days were significantly more likely to have fistula characteristics associated with a favorable repair prognosis. Similarly, while Kriplani and colleagues16 found a significantly higher proportion success among fistulas repaired vaginally, analyses did not account for the severity of the fistula, and it is possible that abdominal repairs were more difficult cases less likely to be successfully repaired. In addition, while Kirschner and coauthors found that use of relaxing incision was associated with poorer prognosis, analyses did not adjust for scarring and stenosis, factors that the authors acknowledge may have indicated use of relaxing incision.19

Several observational studies restricted their samples to women meeting specific criteria. Though preferable to no adjustment, this does not allow for adjustment of multiple confounding factors. For instance, while Browning11 found that a significantly higher proportion of women with a Martius flap experienced residual incontinence after repair, stratified analyses demonstrated that fistulas repaired with Martius flap may have been more difficult. Though differences persisted within select subgroups, the possibility of residual confounding by indication cannot be excluded.11

We have identified several research priorities. First, the endpoint “any incontinence,” does little to inform intervention efforts, since the causes of failure to close a fistula versus causes of residual incontinence cannot be teased out. Future studies should examine fistula closure and residual incontinence separately, in order to clarify the etiological importance of different characteristics and procedures being studied. Where possible, studies examining residual incontinence should employ urodynamic studies (UDS) to enable differentiation between types of incontinence, including stress, urge, overflow and mixed incontinence.

Secondly, post-hoc studies of the predictive value of an individual classification system cannot determine the sufficiency of the systems for predicting repair outcomes, or the superiority of one system over another. For instance, it is possible that patient or fistula characteristics not included in current classification systems are important in predicting repair outcomes. Similarly, the inability of any component of these systems to predict fistula closure may result from inadequate statistical power to detect small differences. In order to develop a single, standardized prognostic system for classifying fistulas, additional research confirming the prognostic value of parameters included in existing classification systems, as well as evaluating factors not included, is needed. It is also important to compare existing classification systems to assess their relative discriminatory value for predicting repair outcomes.

More research is also required to assess which peri-operative factors are associated with repair outcomes, independent of patient or fistula characteristics. In particular, further research is required on factors such as duration of catheterization and route of repair which may be associated with increased hospital stay and risk of health-care associated infection. A standardized system of classifying fistula prognosis will facilitate the conduct of such studies.

In summary, a small, albeit growing, number of empirical studies have examined the relationship between fistula repair outcomes and patient characteristics, fistula characteristics and peri-operative procedures used. Many of the studies we reviewed had relatively small sample sizes and did not use rigorous epidemiologic research methods. This, together with the range of predictors studied and variety of definitions of repair outcomes used, has resulted in lack of a unified evidence-base on most predictor-repair outcome relationships and thus little evidence on which to base clinical practice. Given the material and human resource shortages in the settings in which fistula surgery is often conducted, it is admirable that any data has been accumulated on this patient population. Nonetheless, further research is urgently needed to improve the care and treatment of this marginalized and neglected group of women.

Acknowledgements

We would like to thank Drs. Elaine Larson, Guohua Li and Leslie Davidson from Columbia University, and Erin Mielke from USAID, for their thoughtful reviews of the manuscript.

Sources of financial support: This work was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) which supported the first author’s doctoral research, as well as the United States Agency for International Development (USAID), under the terms of associate cooperative agreement GHS-A-00-07-00021-00. The information provided here does not necessarily reflect the views of the U.S. government.

Footnotes

1We understand heal to refer to fistula closure, given that the proposed mediating mechanism between antibiotic use and surgical outcome was reducing surgical wound infection

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Financial disclosure: None of the authors have a conflict of interest.

Presentation information: This work was presented in part at the 2010 International Society of Fistula Surgeons (ISOFS) conference, 9 December 2010, in Dakar Senegal.

References

1. Wall LL. Obstetric vesicovaginal fistula as an international public-health problem. Lancet. 2006;368:1201–9. [PubMed]
2. National Population Commission (NPC), ORC Macro Nigeria Demographic and Health Survey 2008. NPC and ORC Macro; Calverton, Maryland: 2009.
3. National Statistical Office (NSO), ORC Macro Malawi Demographic and Health Survey 2004. NSO and ORC Macro; Calverton, Maryland: 2005.
4. Browning A. The circumferential obstetric fistula: characteristics, management and outcomes. BJOG. 2007;114:1172–6. [PubMed]
5. Creanga AA, Genadry RR. Obstetric fistulas: a clinical review. Int J Gynaecol Obstet. 2007;99(Suppl 1):S40–6. [PubMed]
6. Goh JT, Browning A, Berhan B, Chang A. Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:1659–62. [PubMed]
7. Raassen TJ, Verdaasdonk EG, Vierhout ME. Prospective results after first-time surgery for obstetric fistulas in East African women. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19:73–9. [PubMed]
8. Holme A, Breen M, MacArthur C. Obstetric fistulae: a study of women managed at the Monze Mission Hospital, Zambia. BJOG. 2007;114:1010–7. [PubMed]
9. Lewis A, Kaufman MR, Wolter CE, et al. Genitourinary fistula experience in Sierra Leone: review of 505 cases. J Urol. 2009;181:1725–31. [PubMed]
10. Melah GS, El-Nafaty AU, Bukar M. Early versus late closure of vesicovaginal fistulas. Int J Gynaecol Obstet. 2006;93:252–3. [PubMed]
11. Browning A. Lack of value of the Martius fibrofatty graft in obstetric fistula repair. Int J Gynaecol Obstet. 2006;93:33–7. [PubMed]
12. Chigbu CO, Nwogu-Ikojo EE, Onah HE, Iloabachie GC. Juxtacervical vesicovaginal fistulae: outcome by route of repair. J Obstet Gynaecol. 2006;26:795–7. [PubMed]
13. Nardos R, Browning A, Member B. Duration of bladder catheterization after surgery for obstetric fistula. Int J Gynaecol Obstet. 2008;103:30–2. [PubMed]
14. Rangnekar NP, Ali N Imdad, Kaul SA, Pathak HR. Role of the martius procedure in the management of urinary-vaginal fistulas. J Am Coll Surg. 2000;191:259–63. [PubMed]
15. Olusegun AK, Akinfolarin AC, Olabisi LM. A review of clinical pattern and outcome of vesicovaginal fistula. J Natl Med Assoc. 2009;101:593–5. [PubMed]
16. Kriplani A, Agarwal N, Parul, Gupta A, Bhatla N. Observations on aetiology and management of genital fistulas. Arch Gynecol Obstet. 2005;271:14–8. [PubMed]
17. Nardos R, Browning A, Chen CC. Risk factors that predict failure after vaginal repair of obstetric vesicovaginal fistulae. Am J Obstet Gynecol. 2009;200:578, e1–4. [PubMed]
18. Browning A. Risk factors for developing residual urinary incontinence after obstetric fistula repair. BJOG. 2006;113:482–5. [PubMed]
19. Kirschner C, Yost K, Du H, Karshima J, Arrowsmith S, Wall L. Obstetric fistula: the ECWA Evangel VVF Center surgical experience from Jos, Nigeria. International Urogynecology Journal. 21:1525–33. [PubMed]
20. Morhason-Bello IO, Ojengbede OA, Adedokun BO, Okunlola MA, Oladokun A. Uncomplicated midvaginal vesico-vaginal fistula repair in Ibadan: A comparison of the abdominal and vaginal routes. Annals of Ibadan Postgraduate Medicine. 2008;6:39–43.
21. Murray C, Goh JT, Fynes M, Carey MP. Urinary and faecal incontinence following delayed primary repair of obstetric genital fistula. BJOG. 2002;109:828–32. [PubMed]
22. Bland KG, Gelfand M. The influence of urinary bilharziasis on vesico-vaginal fistula in relation to causation and healing. Trans R Soc Trop Med Hyg. 1970;64:588–92. [PubMed]
23. Tomlinson AJ, Thornton JG. A randomised controlled trial of antibiotic prophylaxis for vesico-vaginal fistula repair. Br J Obstet Gynaecol. 1998;105:397–9. [PubMed]
24. Muleta M, Tafesse B, Aytenfisu HG. Antibiotic use in obstetric fistula repair: single blinded randomized clinical trial. Ethiop Med J. 2010;48:211–7. [PubMed]
25. Safan A, Shaker H, Abdelaal A, Mourad MS, Albaz M. Fibrin glue versus martius flap interpositioning in the repair of complicated obstetric vesicovaginal fistula. A prospective multi-institution randomized trial. Neurourol Urodyn. 2009;28:438–41. [PubMed]
26. Browning A. Prevention of residual urinary incontinence following successful repair of obstetric vesico-vaginal fistula using a fibro-muscular sling. BJOG. 2004;111:357–61. [PubMed]
27. Wall LL, Arrowsmith SD, Briggs ND, Browning A, Lassey A. The obstetric vesicovaginal fistula in the developing world. Obstet Gynecol Surv. 2005;60:S3–S51. [PubMed]
28. Walker AM. Confounding by indication. Epidemiology. 1996;7:335–6. [PubMed]
29. Waaldijk K. Surgical classification of obstetric fistulas. Int J Gynaecol Obstet. 1995;49:161–3. [PubMed]
30. Goh JTW. A new classification for female genital tract fistula. Aust N Z J Obstet Gynaecol. 2004;44:502–4. [PubMed]